SCHEMBL23958178

SCHEMBL23958178

O=c1c2cc(F)ccc2nc(Nc2ccncn2)n1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 3/20 0.43
PIK3CG P48736 2/20 0.43
TDO2 P48775 2/20 0.43
IDO2 Q6ZQW0 2/20 0.43
PIK3C3 Q8NEB9 1/20 0.43
PIK3R1 P27986 2/20 0.43
PIK3CB P42338 2/20 0.41
PIK3CA P42336 1/20 0.41
USP2 O75604 4/20 0.41
CYP1A2 P05177 4/20 0.41
CYP3A4 P08684 3/20 0.41
CYP2C9 P11712 3/20 0.41
CYP2C19 P33261 3/20 0.41
HSD17B10 Q99714 2/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 2/20 0.40
CYP2D6 P10635 1/20 0.40
POLB P06746 1/20 0.40
IDO1 P14902 1/20 0.40
HTR7 P34969 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23958125 0.88 MAT2A (0.47) PIK3CDPIK3CGTDO2IDO2PIK3C3
SCHEMBL23958261 0.87 TUBB4A (0.47) PIK3CDPIK3CGPIK3R1USP2CYP1A2
SCHEMBL24111012 0.86 BTK (0.50) PIK3CDPIK3CGTDO2IDO2PIK3C3
SCHEMBL30103221 0.85 TDO2 (0.46) PIK3CDPIK3CGTDO2IDO2PIK3C3
SCHEMBL24111048 0.85 TDO2 (0.46) PIK3CDPIK3CGTDO2IDO2PIK3C3
SCHEMBL30103197 0.85 PIK3CB (0.47) PIK3CDPIK3CGTDO2IDO2PIK3C3
SCHEMBL24110790 0.85 PIK3CB (0.47) PIK3CDPIK3CGTDO2IDO2PIK3C3
SCHEMBL23958194 0.84 TDO2 (0.46) PIK3CDPIK3CGTDO2IDO2PIK3C3
SCHEMBL24110965 0.82 POLB (0.49) PIK3CDPIK3CGTDO2IDO2PIK3C3
SCHEMBL23958277 0.82 POLB (0.49) PIK3CDPIK3CGTDO2IDO2PIK3C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed
WO-2021215537-A1 2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE 大日本住友製薬株式会社 (JP) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 PIK3CD 3088/4885PIK3CG 3250/4885TDO2 1621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.